The Exchange has sought clarification from Aurobindo Pharma Ltd on January 28, 2019, with reference to news appeared in www.economictimes.com dated January 27, 2019 quoting "Aurobindo recalls nearly 5 lakh bottles of blood pressure drug in US".
The reply is awaited.